TDK Corporation has divested its medical business HTI Medical to GTCR-backed Resonetics

Hutchinson Technology, Inc., a subsidiary of TDK Corporation, has sold its medical business HTI Medical to Resonetics, a portfolio company of GTCR.

HTI Medical manufactures and assembles tight-tolerance metal components principally for medical devices used to seal vessels in minimally invasive and open surgery. The company has proprietary processes to chemically etch blades, create ceramic features on metal substrates and fabricate miniaturized electromechanical sensors for hand-held and robotic surgical instruments.

Resonetics is a pioneer in micro-manufacturing, serving the life sciences industry. The acquisition of HTI Medical will expand its precision manufacturing capabilities. GTCR is a leading private equity firm which has invested more than US$18 billion in over 200 companies.

TDK Corporation, together with its subsidiaries, manufactures and sells electronic components in Japan, Europe, China, Asia, the Americas and internationally.

One of Oaklins’ teams in the USA served as the exclusive financial advisor to Hutchinson Technology, Inc., a subsidiary of TDK Corporation. The team in Irvine had advised TDK on its prior acquisition of the parent of HTI Medical, Hutchinson Technology, and referred this transaction to the team.